# Dexmedetomidine to Lessen Intensive Care Unit (ICU) Agitation

> **NCT01151865** · PHASE2,PHASE3 · COMPLETED · sponsor: **Austin Health** · enrollment: 96 (actual)

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Saline placebo

## Key facts

- **NCT ID:** NCT01151865
- **Lead sponsor:** Austin Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2015-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151865, "Dexmedetomidine to Lessen Intensive Care Unit (ICU) Agitation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01151865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*